A conceptually simple and direct synthetic route to racemic saframycin B, a bis-isoquinoline quinone antitumor antibiotic, was studied relying on transformations of a key C-2 symmetric intermediate.
A conceptually simple and direct synthetic route to racemic saframycin B, a bis-isoquinoline quinone antitumor antibiotic, was studied relying on transformations of a key C-2 symmetric intermediate.